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1. Introduction 
Human intestine malignant epithelial cells store 
glycogen in vivo [1,2] and in vitro [2,3]. Studies per- 
formed in vitro with established cell lines have shown 
that the quantity of glycogen stored varies from one 
cell line to another, is closely related to the process of 
cell growth, and represents a characteristic feature of 
each cell line [2,3]. These same cell lines have been 
shown to possess an adenylate cyclase system which is 
highly sensitive to the vasoactive intestinal peptide 
(VIP) [4,5]. In view of the known effect of cyclic 
AMP on glycogenolysis in various systems [6], it 
seemed justified to investigate whether VIP was able 
to stimulate glycogenolysis in such cell lines in culture. 
The cell line HT-29 was selected for this study. It ori- 
ginates from a well-differentiated colon adenocarci- 
noma [7], and was chosen for the following reasons: 
(1) Its cyclic AMP production system is highly sen- 
sitive to VIP [4,5]; 
(2) VIP elicits an activation of cyclic AMP-depen- 
dent protein kinases in these cells [8]; 
(3) Their glycogen content falls in the middle of the 
range of the values found in the different intestine 
cell lines so far investigated [2,3]. 
Our data show that VIP provokes a cascade of 
events involving an increase of cyclic AMP, an activa- 
tion of glycogen phosphorylase, and a subsequent gly- 
cogenolysis in monolayers of exponentially growing 
HT-29 cells. 
2. Materials and methods 
2.1. Cell cultures and incubation procedures 
The cells were seeded at 0.5 X lo6 cells/flask in 
25 cm* plastic flasks (Corning) and cultured at 37°C 
in Dulbecco’s modified Eagle’s medium supplemented 
with 10% fetal bovine serum (Gibco, Grand Island, NY), 
in an atmosphere of 90% air/IO% CO*. The medium 
was changed after 60 h and VIP added to the culture 
medium 12 h later. The incubation was performed at 
37°C. The number of cells at the moment of the 
assay was -4 X lo6 cells/flask (= 1 mg protein). For 
cyclic AMP and glycogen phosphorylase assays, the 
culture medium was rapidly removed, the cells rapidly 
washed with ice-cold phosphate-buffered saline Ca’+- 
and Mg’+-free (PH 7.2) and immediately snap frozen by 
flotation of the flasks on a bath of liquid nitrogen. The 
flasks were stored at -70°C for subsequent extraction. 
For the glycogen and protein assays, the cells were 
harvested with trypsin 0.25%, divided equally, cen- 
trifuged (5 min, 4°C 100 X g) and washed twice in 
ice-cold phosphate-buffered saline, and stored at 
-70°C. 
2.2. Glycogen and protein quantitative assays 
Glycogen was extracted from the cells and measured 
with anthrone (Sigma) as in [2-41, according to the 
method in [9], as modified [lo]. The method with 
anthrone was found to have the same sensitivity as 
that using glucose oxydase. The protein content was 
measured by the method in [ll]. 
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2.3. Glycogen phuspho~lase assay 
For enzyme extraction, an ice-cold buffer (pH 7.4) 
containing 62.5 mM glycyl-glycine, 6.25 mM EDTA, 
125 mM NaF, 0.5 M saccharose, and 5 mM dithio- 
threitol was added to the flasks, and the frozen cell 
layers were scraped with a rubber policeman. The 
volume of the buffer was adjusted to -3 mg cell 
protein~~. The cells were disrupted by multiple pas- 
sages through a 26 G needle, and centrifuged (30 min, 
4°C 800 X g). Glycogen phospho~lase was assayed 
according to /12], modified by the addition of caf- 
feine (1 mM) [ 131, by measuring the incorporation of 
[‘4C]glucose-l-phosphate into rabbit liver glycogen 
(Sigma), in the presence of AMP (Sigma) for total 
enzyme activity, and without AMP for phosphorylase 
a activity. 
2 -4. Cyclic AMP assay 
Cyclic AMP was extracted from the cells by thaw- 
ing and scraping the frozen cell layers in methanol at 
room temperature. The methanol extract was cen- 
trifuged (15 min, 4”C, 800 X g) and evaporated. Cyclic 
AMP was measured by the modified [14] radioim- 
munologic~ technique of [ 151. 
3. Results and discussion 
ln 141, with detached cells, at 15’C, and in the 
presence of a phosphodiesterase inhibitor, the optimum 
concentration of VIP necessary to elicit a rn~~urn 
accumulation of cyclic AMP in HT-29 cells was 
10v9 M. As this study involved the use of monolayers 
of exponentially growing cells, at 37OC, and no phos- 
phodiesterase inhibitor, a dose-effect study of VIP 
on glycogenolysis was done before further investiga- 
tion. Fig.1 shows that under such experimental con- 
ditions the optimum concentration of VIP required 
to elicit a maximum glycogenolytic effect in HT-29 
cells was 10m8 M. 
In all 3 expt performed at different cell passages, 
VIP at lo-’ M induced the same changes in the same 
invariable order of sequence (iig.2): cyclic AMP rap- 
idly increased, from a basal value of 0.77 + 0.05 pmolf 
mg protein up to a peak (--40-times higher than the 
basal) at 30 s. This peak was followed by a rapid 
decrease; a plateau was reached after 5 min which 
remained constant for 3 hand was still 1 O-times higher 
than the basal value. The activity of glycogen phos- 
phorylase a increased from the initial value of 
Fig.1. Dose-effect of VIP on glycogenolysis in monolayers 
of exponentially growing NT-29 cells. Giycogen was measured 
after 60 min incubation. Each point is the mean of 3 separate 
expt. SD values (not shown) are <lo%. 
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Fig.2 Effect of VIP (1 O-’ M) on cyclic AMP accumulation 
(top), glycogen phosphoryhse a activity (middle), and intra- 
cellular glycogen concentration (bottom) in monolayers of 
exponentially growing HT-29 cells. Each paint is the mean of 
3 separate xpt. 
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Fig.3. Glycogenolytic effect of dibutyrylcyclic AMP (1 OS3 M) 
in monolayers of exponentially growing HT-29 cells. Each 
point is the mean of 4 different expt. SD values (not shown) 
are <lo%. 
40 rt 3 nmol . mm-*. mg protein-i to twice this value 
2 min later. The activity gradually fell off; after 30 min 
a plateau was reached which again remained stable for 
3 h and stayed higher than the control. These varia- 
tions of the a form of glycogen phosphorylase con- 
trasted with the constancy of the total activity of the 
enzyme (100.9 + 5.2 nmol . mm-‘. mg protein-“, not 
shown in fig.2). The concentration of glycogen began 
to decrease after 5 min. This decrease was slow, starting 
from 23.4 t 0.4 I.tg ~ycogen~mg protein, and dropped 
to a minimum value of 11.7 f 0.9 pg at 90 min. At 
6 h after the addition of VIP (not shown in fig.2), the 
concentration of cyclic AMP had decreased to double 
the basal value, the activity of phosphorylase a was 
back to the control value, while the concentration of 
glycogen still remained lower than the control (80%). 
The transient effect of VIP was not due to its degra- 
dation in the culture medium. indeed, the concentra- 
tion of VIP in the culture medium, after 6 h, was still 
sufficient to elicit a maximum stimulation of cyclic 
AMP accumulation in fresh HT-29 cells. Therefore, 
further studies need to be undertaken to check if this 
transient effect is due to a desensitisation process. 
The addition of dibutyryl cyclic AMP (low3 M) to 
the culture medium produced the same degree of 
glycogenolysis as that induced by VIP (fig.3). The 
glycogenolytic effect produced by dibutyryl cyclic 
AMP was however much slower, starting after 2 h, 
and reaching its maximum value at 24-48 h. This 
delayed effect is probably due to a low permeation 
of dibutyryl cyclic AMP into the cells, in the same 
way as has been described in HeLa cells [ 171. 
These data confirm that HT-29 cells retain an aden- 
ylate cyclase system with a sensitivity to VIP similar 
to that of normal human colocytes [4,5,16]. They 
demonstrate that these cells also possess a functional 
40 
cyclic _~P-dependent metabolic pathway of glyco- 
genolysis. 
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